- STAFF PICKS
- GIFTS + GIFT CARDS
- SELL BOOKS
- FIND A STORE
Ships in 1 to 3 days
Other titles in the Basic and Clinical Oncology series:
Medical Management of Hematological Malignant Diseasesby Emil J. Freireich and Hagop M. Kantarjian.
Synopses & Reviews
A comprehensive guide in treating hematological malignancies, Medical Management of Hematological Malignant Diseases offers practical lessons for patient care and addresses a wide range of special topics from infection to transplantation to molecular biology.
Describes the application of the polymerase chain reaction (PCR) to the detection and quantitation of residual malignant cells
With discussions of dose intensive chemotherapy, stem cell transplantations, and leukemia sensitization, Medical Management of Hematological Malignant Diseases
examines the use of induction therapy in the management of acute myeloid leukemia
highlights bone marrow transplantation as an effective postremission strategy
explores circumvention of multidrug resistance as an alternative procedure
traces progress in treating hairy cell leukemia
charts the success of all-trans retinoic acid in treating acute promyelocytic leukemia
weighs the risks and benefits of myelodysplastic treatments
discusses small lymphocytic lymphoma, follicular small cleaved cell lymphoma, and other lymphomas
suggests approaches for the treatment of primary and relapsed Hodgkin's disease
focuses on new or rediscovered chemotherapeutic agents, monoclonal antibodies, and immune modulation
Including over 2800 references and illustrations, Medical Management of Hematological Malignant Diseases provides a clearinghouse of information for hematologists, oncologists, cancer researchers, internists, and residents, fellows, and medical school students in these disciplines.
Book News Annotation:
Focuses on basic therapeutic research for the broad spectrum of malignant diseases of the hematological organs. Part I deals with the leukemias, and Part II is devoted to lymphomas, with emphasis on the distinction between management of Hodgkin's disease and other lymphoid malignancies. Part III updates plasma cell malignancies for both multiple myeloma and Waldenstrom's macroglobulinemia. Part IV is devoted to special aspects of the medical management of malignant diseases, including the rapidly changing spectrum of infections, hematopoietic growth factors, and the role of allogenic stem-cell transplantation in the management of these diseases.
Annotation c. Book News, Inc., Portland, OR (booknews.com)
Text focusing on basic therapeutic research to the broad spectrum of malignant diseases of the hematological organs. For physicians-scientists and physicians who care for patients with hematological malignancies and other forms of cancer.
What Our Readers Are Saying